Various organisms store energy in a form of neutral lipids such as triacylglycerol (TG) and cholesteryl ester (CE). In mammals, these neutral lipids are intracellularly stored as typically seen in adipocytes, hepatocytes, steroidogenic cells and macrophage-derived foam cells. Storage of lipids has merits allows for energy preservation and synthesis of lipoproteins and steroid hormones. However, excess accumulation often leads to disorders such as obesity, fatty liver and atherosclerosis.1) It is therefore important to understand how neutral lipids are stored and mobilized intracellularly, as these mechanisms largely remain unclear. In animal cells, neutral lipids are deposited in intracellular compartments called lipid droplets (LDs, also called lipid storage droplets, lipid bodies or lipid particles). TG and CE are packed in LDs coated with phospholipid monolayer.
2,3)The liver is the center of lipid metabolism in the body. It recovers and synthesizes lipid molecules and reconstitutes them as lipoproteins such as very low-density lipoprotein (VLDL), which are secreted into the circulation and distributed throughout the body. Thus, hepatic cells are important stores of neutral lipids and act as a physiological buffer. Increased accumulation of neutral lipids often causes fatty liver disease accompanied by LD formation in the hepatocytes. Recently, attention has been focused on hepatic steatosis as a part of the metabolic syndrome since this is intimately related to other signs and symptoms of the syndrome including obesity, hypertension, insulin resistance, hyperglycemia and hyperlipidemia.4) Hepatic steatosis is also induced by factors other than nutrients, including drugs and toxic reagents.
5)In this study, we tested LD-induction activity of fatty acids and glucose, which can cause hepatic steatosis, using a human hepatocyte cell line; this suggested that long-chain free fatty acids (FFA) most effectively induce LDs. We also tested various compounds as to whether they could suppress LD formation induced by oleic acid (OA), a long chain FFA. The LD formation was effectively blocked by an inhibitor of long chain acyl-CoA synthetase (ACSL). These results suggest that long chain FFAs and ACSLs are significant factors in LD formation in hepatocytes.
MATERIALS AND METHODSMaterials HuH7, a human hepatocyte cell line, was obtained from Health Science Research Resources Bank (cell no. JCRB0403; Osaka Japan). Fatty acids (as sodium salt) and 5-pregnen-3b-ol-20-one (pregnenolone) were purchased from Sigma (U.S.A.). Caffeine, capsaicin, carbon tetrachloride and dl-isoproterenol hydrochloride were purchased from Wako (Japan). Triacsin C was purchased from Kyowa Medex (Japan). 4,4,10b-Trimethyl-trans-decal-3b-ol (AMO 1618) was purchased from Calbiochem (U.S.A.). Anti-ADRP monoclonal antibody was purchased from PROGEN (Germany). Anti-17bHSD11 antiserum was prepared as described previously.6) Peroxidase-conjugated goat anti-IgG antibodies were purchased from Biosource International (Camarillo, California). ECL Western Blotti...